News Releases

Below are the latest News Releases for Clearmind Medicine Inc.

25

September

2025

Clearmind Medicine Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies
Read More
19

September

2025

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
Read More
7

August

2025

Clearmind Announces International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
Read More
5

August

2025

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Read More
30

July

2025

Clearmind Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
Read More
23

July

2025

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
Read More
15

July

2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled
Read More
3

July

2025

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for AUD at Tel Aviv Sourasky Medical Centre
Read More
30

June

2025

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for AUD
Read More
27

June

2025

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
Read More
23

June

2025

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
Read More
12

June

2025

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Read More
5

June

2025

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment
Read More
12

May

2025

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
Read More
25

April

2025

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
Read More